Latest in Research & Development

Merck's sacituzumab tirumotecan granted Breakthrough Therapy Designation by the FDA

The antibody-drug conjugate (ADC) can be used to treat patients with advanced or metastatic non-small cell lung cancer (NSCLC)

Find out more

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space,...
See more

Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development

Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
You need to be a subscriber to read this article.
Click here to find out more.

Hybrid interferons: developing a novel drug class

With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These challenges can be further amplified if the candidate being developed is of an entirely novel drug class

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies

Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics

Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio

Steritas and argenx join forces to advance steroid-sparing therapeutic development

With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

Latest posts in Research & Development

Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre

The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes

BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities

The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation

Transmission Raman Spectroscopy - access the webinar series today

Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series

Syncona launches early-stage drug development company, Slingshot Therapeutics

The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease

Medac and chiron develop organ-on chip tech for animal free drug testing

The companies aim to develop an animal-free pharmaceutical testing method that utilises organ-on chip technology, and will be used in rheumatoid arthritis drug testing

AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial

The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously

Asymchem develops AI platform to optimise protein design in drug development

Sequence Recommendation via Artificial Intelligence (STAR) addresses key challenges in protein design through intelligent algorithms and data-driven insights

Fujifilm Diosynth Biotechnologies expands its biologic manufacturing capabilities at Hillerød site

The CDMO's first expansion phase introduces six more 20,000 L bioreactors and two downstream processing streams to the facility

Strategic partnership announced to develop ATMPs

CCRM Nordic, Sahlgrenska Academy, and Sahlgrenska University Hospital are forming a strategic partnership relating to advanced therapy medicinal products (ATMPs)

Lonza's Synaffix and BigHat Biosciences team up to develop ADC pipeline programme

Synaffix's clinical-stage ADC platform technology will allow BigHat to expand and progress its ADC pipeline for oncological indications

Neogap Therapeutics and NorthX Biologics team up to scale novel cancer cell therapy

CDMO NorthX Biologics will work with Neogap to determine advanced manufacturing protocols for Neogap's personalised cancer cell therapy

Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m

Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases

Sponsor content

Guardtech Group hoping to end golden year with more success at SME National Business Awards

Suffolk contamination control experts looking to add Best Enterprising Business prize to epic 2024 awards haul at glitzy Wembley Stadium showpiece on 6 December

ACG launches ADAPT X at CPhI & PMEC India 2024

Innovative tablet feeder sets new benchmarks for efficiency and versatility in pharmaceutical packaging solutions

Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme

AI-driven approach promises a new class of depression treatment

Anton Paar expands Litesizer DIA Series with new models

Introducing affordable and advanced solutions for particle analysis

Triple your efficiency with the new DrySyn Vortex

Boost productivity with temperature-controlled parallel reactions

Five critical design elements for Pelton wheel turbine flowmeters

Titan Enterprises outlines the factors for cost-effective and reliable low-flow measurement

Efficient PFAS-free degassing of aqueous solutions

New silicone-based degassing chamber eliminates the risk of PFAS contamination

How flow chemistry is transforming drug discovery

New Syrris eBook explores techniques driving efficiency and innovation

IMed Consultancy enabling innovation in the mental healthcare sector with Limbic

Limbic is a London-based start-up that is using world-leading, clinically validated Artificial Intelligence and beautiful product design to make psychological therapy...

Dissolution of an immediate release nanoparticle formulation using the NanoDis system

An efficient dissolution method to aid in nanoparticle drug development

INTEGRA Bioscience's pipettes for streamlined and accurate liquid handling

Bioanalytical consultancy company BioApp solutions is currently using INTEGRA's pipettes to improve its pipetting consistency, and — therefore — the reproducibility of...

PacBio launches Vega system, a compact long-read sequencing platform

New benchtop sequencer brings HiFi technology to researchers at $169,000

Featured companies

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug... Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or... The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech... At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable.
See more